Shanghai Neo-Medical Import & Export Co., Ltd.
Letter data
- Company
- Shanghai Neo-Medical Import & Export Co., Ltd.
- Recipient
- Pei Zhang | General Manager | Shanghai Neo-Medical Import & Export Co., Ltd. | Room 2004, B/D3 | 183 Huai Hai Xi Rd. | Shanghai Shi | , | 200000 | China
- Issue date
- 2020-06-16
- Posted date
- Not available
- FDA office
- Division of Infection Control and Plastic Surgery Devices
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 477444
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Shanghai Neo-Medical Import & Export Co., Ltd.
MARCS-CMS 477444 —
June 16, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Product:
Medical Devices
Recipient:
Recipient Name
Pei Zhang
Recipient Title
General Manager
Shanghai Neo-Medical Import & Export Co., Ltd.
Room 2004, B/D3
183 Huai Hai Xi Rd.
Shanghai Shi
,
200000
China
Issuing Office:
Division of Infection Control and Plastic Surgery Devices
United States
Dear Mr. Zhang:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS # 477444, dated November 10, 2015). Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely yours,
/S/
Cynthia J. Chang, Ph.D.
Director
Division of Infection Control and Plastic Surgery
Devices
Office of Health Technology 4: Surgical and
Infection Control Devices
Center for Devices and Radiological Health
CC:
Marco Mu
Mid-link International Inc
2219 Rimlang Drive, Suite 301
Bellingham, WA US 98226
Content current as of:
06/23/2020
Regulated Product(s)
Medical Devices